Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of gestational malaria in Kisangani
PACTR201905899965726Not yet recruiting
- Sponsor
- University of Kisangani
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mefloquine and sulfadoxine + pyrimethamine in Placental Malaria (PM) (2 arms), sponsored by University of Kisangani. Planned start May 2019; status: not yet recruiting.
02
Drugs
mefloquinesulfadoxine + pyrimethamine
03
Conditions
Placental Malaria (PM)
Beyond the preview
Go deeper on PACTR201905899965726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201905899965726.